{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:34:56Z","timestamp":1793799296079,"version":"4.6.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.esmoop.2026.108601","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:18:37Z","timestamp":1792012717000},"page":"108601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Structured physical activity in high-risk stage II and stage III colon cancer: tertiary prevention of colorectal cancer recurrence or primary prevention in a population at high risk of secondary cancers?"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8456-9269","authenticated-orcid":false,"given":"R.","family":"Moretto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Conca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9566-4579","authenticated-orcid":false,"given":"E.","family":"Blondeaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cremolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.esmoop.2026.108601_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa2502760","article-title":"Structured exercise after adjuvant chemotherapy for colon cancer","volume":"393","author":"Courneya","year":"2025","journal-title":"N Engl J Med"},{"issue":"35","key":"10.1016\/j.esmoop.2026.108601_bib2","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1200\/JCO.2015.63.4238","article-title":"Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study","volume":"33","author":"Andr\u00e9","year":"2015","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108601_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2025.106019","article-title":"ESMO clinical practice guideline express update on the adoption of physical exercise in patients with localised colon cancer","volume":"11","author":"Pentheroudakis","year":"2026","journal-title":"ESMO Open"},{"issue":"13","key":"10.1016\/j.esmoop.2026.108601_bib4","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMoa1713709","article-title":"Duration of adjuvant chemotherapy for stage III colon cancer","volume":"378","author":"Grothey","year":"2018","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.esmoop.2026.108601_bib5","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1200\/JCO.2015.63.0558","article-title":"Impact of patient factors on recurrence risk and time dependency of oxaliplatin benefit in patients with colon cancer: analysis from modern-era adjuvant studies in the adjuvant colon cancer end points (ACCENT) database","volume":"34","author":"Shah","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.esmoop.2026.108601_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejca.2020.02.009","article-title":"Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: results of the DATECAN initiative","volume":"130","author":"Cohen","year":"2020","journal-title":"Eur J Cancer"},{"issue":"23","key":"10.1016\/j.esmoop.2026.108601_bib7","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1056\/NEJMoa032709","article-title":"Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer","volume":"350","author":"Andr\u00e9","year":"2026","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108601_bib8","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3390\/jcm15031053","article-title":"Second primary malignancies in patients with colorectal cancer: the frequency, types, and timeline","volume":"15","author":"Lerner","year":"2026","journal-title":"J Clin Med"},{"issue":"22","key":"10.1016\/j.esmoop.2026.108601_bib9","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1200\/JCO-26-00765","article-title":"Structured exercise program following adjuvant chemotherapy for colon cancer: a cost-utility analysis of the CHALLENGE trial","volume":"44","author":"Chan","year":"2026","journal-title":"J Clin Oncol"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926025469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926025469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:20:28Z","timestamp":1793798428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702926025469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":9,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2059702926025469"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.108601","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structured physical activity in high-risk stage II and stage III colon cancer: tertiary prevention of colorectal cancer recurrence or primary prevention in a population at high risk of secondary cancers?","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.108601","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2025.106019","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"108601"}}